Determinants for HPV vaccine uptake in the Netherlands: A multilevel study

Vaccine

Volumn 28, Issue 9, 2010, Pages 2070-2075

  Rondy, Marc ^a,b   van Lier, Alies ^a   van de Kassteele, Jan ^a   Rust, Laura ^c   de Melker, Hester ^a  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^b EUROPEAN CENTRE FOR DISEASE PREVENTION AND CONTROL ECDC   (Sweden)

^c Netherlands Association for Community Health Services (GGD Nederland)   (Netherlands)

Author keywords

Human papillomavirus vaccines; Multilevel study; Vaccine uptake

Indexed keywords

MEASLES MUMPS RUBELLA VACCINE;

ARTICLE; ETHNIC GROUP; FEMALE; GYNECOLOGY; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; MEASLES; MEDICAL INFORMATION; MUMPS; NETHERLANDS; POLITICAL SYSTEM; PRIORITY JOURNAL; RUBELLA; SCHOOL; SCREENING; SOCIAL STATUS; UTERINE CERVIX;

ADOLESCENT; DATA COLLECTION; DELIVERY OF HEALTH CARE; FEMALE; HEALTH EDUCATION; HUMANS; IMMUNIZATION PROGRAMS; LOGISTIC MODELS; NETHERLANDS; PAPILLOMAVIRUS VACCINES; PATIENT ACCEPTANCE OF HEALTH CARE; POLITICS;

EID: 76949099845     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.12.042     Document Type: Article

References (26)

1. Boeke A.J.P. Advisory report from the Health Council of the Netherlands to include human papillomavirus vaccination in the National Immunisation Programme for the prevention of cervical cancer [In Dutch]. Ned Tijdschr Geneeskd 152 (2008) 981-983
2. ® product information: human papillomavirus vaccine type 16 and 18 (Recombinant AS04 adjuvanted); 2007.
3. Humiston S.G., and Rosenthal S.L. Challenges to vaccinating adolescents: vaccine implementation issues. Pediatr Infect Dis J 24 6 Suppl. (2005) S134-S140
4. Raffle A.E. Challenges of implementing human papillomavirus (HPV) vaccination policy. BMJ 335 7616 (2007) 375-377
5. (Nederlandse-Kankerregistratie) Drfc. Incidentie cijfers In, IKCnet; 2009.
6. Gustafsson L., Ponten J., Zack M., and Adami H.O. International incidence rates of invasive cervical cancer after introduction of cytological screening. Cancer Causes Control 8 5 (1997) 755-763
7. Knol F. From high to low; from low to high: the social development of districts between 1971 and 1995 [In Dutch]. The Hague; The Netherlands institute for Social Research, 1998.
8. Gelman A., and Hill J. Data analysis using regression and multilevel-hierarchical models (2007)
9. van Lier A. Diphtheria, pertussis, tetanus vaccine uptake per ethnicity-Unpublished data. RIVM; 2009.
10. Brabin L., Roberts S.A., Stretch R., Baxter D., Chambers G., Kitchener H., et al. Uptake of first two doses of human papillomavirus vaccine by adolescent schoolgirls in Manchester: prospective cohort study. BMJ 336 7652 (2008) 1056-1058
11. De Graaf H, Meijer S, Poelman J, Vanwesenbeeck I. Sex under 25 years old, sexual health of youngs in the Netherlands in 2005 [In Dutch]. Rutgers Nisso Groep and Soa Aids Nederland, Delft, Eburon, Delft; 2005.
12. Dempsey A.F., Zimet G.D., Davis R.L., and Koutsky L. Factors that are associated with parental acceptance of human papillomavirus vaccines: a randomized intervention study of written information about HPV. Pediatrics 117 5 (2006) 1486-1493
13. Marlow L.A., Waller J., and Wardle J. Sociodemographic predictors of HPV testing and vaccination acceptability: results from a population-representative sample of British women. J Med Screen 15 2 (2008) 91-96
14. Sanders G.D., and Taira A.V. Cost-effectiveness of a potential vaccine for human papillomavirus. Emerg Infect Dis 9 1 (2003) 37-48
15. van Lier A., Oomen P., Oostenbrug M., Zwakhals S., Drijfhout I., de Hoogh P., et al. High vaccination coverage for the National immunization programme in the Netherlands [In Dutch]. Ned Tijdschr Geneeskd B370 (2009) 153
16. Sobotka T., and Adiguzel F. Religiosity and spatial demographic differences in the Netherlands (2002), University of Groningen, Groningen
17. Hahné S., Abbink F., van Binnendijk R., Ruijs W., van Steenbergen J., and de Melker H. Rubella epidemic in the Netherlands, 2004/'05: awareness of congenital rubella syndrome required. Ned Tijdschr Geneeskd 149 (2005) 1174-1178
18. Zimet G.D., Mays R.M., Sturm L.A., Ravert A.A., Perkins S.M., and Juliar B.E. Parental attitudes about sexually transmitted infection vaccination for their adolescent children. Arch Pediatr Adolesc Med 159 2 (2005) 132-137
19. Constantine N.A., and Jerman P. Acceptance of human papillomavirus vaccination among Californian parents of daughters: a representative statewide analysis. J Adolesc Health 40 2 (2007) 108-115
20. van Leeuwen A.W., de Nooijer P., and Hop W.C. Screening for cervical carcinoma. Cancer 105 5 (2005) 270-276
21. Newmann S.J., and Garner E.O. Social inequities along the cervical cancer continuum: a structured review. Cancer Causes Control 16 1 (2005) 63-70
22. Stone E.G., Morton S.C., Hulscher M.E., Maglione M.A., Roth E.A., Grimshaw J.M., et al. Interventions that increase use of adult immunization and cancer screening services: a meta-analysis. Ann Intern Med 136 9 (2002) 641-651
23. Sturm L.A., Mays R.M., and Zimet G.D. Parental beliefs and decision making about child and adolescent immunization: from polio to sexually transmitted infections. J Dev Behav Pediatr 26 6 (2005) 441-452
24. Malam S, Kirwan S, Mackey T, Romanou E. Childhood Immunisation - wave 32 (England) report - December 2008; 2008.
25. Calloway C., Jorgensen C.M., Saraiya M., and Tsui J. A content analysis of news coverage of the HPV vaccine by U.S. newspapers, January 2002-June 2005. J Womens Health (Larchmt) 15 7 (2006) 803-809
26. Friedman A.L., and Shepeard H. Exploring the knowledge, attitudes, beliefs, and communication preferences of the general public regarding HPV: findings from CDC focus group research and implications for practice. Health Educ Behav 34 3 (2007) 471-485